Keywords
Urinary Bladder Neoplasms ×
Show more Keywords
Table of contents
  1. 1. Clinical Trial
  2. 2. Routine Documentation
  3. 3. Registry/Cohort Study
  4. 4. Quality Assurance
  5. 5. Data Standard
  6. 6. Patient-Reported Outcome
  7. 7. Medical Specialty
Selected data models

You must log in to select data models for download or further analysis.

72 Search results.

Eligibility Solid Tumors, NSCLC, Biliary and Bladder Cancer NCT02240238

- 10/1/20 - 1 form, 2 itemgroups, 9 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Combination Therapy With NC-6004 and Gemcitabine in Advanced Solid Tumors or Non-Small Cell Lung, Biliary and Bladder Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT02240238

Eligibility Bladder Cancer NCT01954173

- 8/18/19 - 1 form, 2 itemgroups, 16 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Adjuvant Radiation for High Risk Bladder Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT01954173

Eligibility Locally Advanced or Metastatic Urothelial Cell Carcinoma NCT02401542

- 4/29/19 - 1 form, 1 itemgroup, 10 items, 1 language
Itemgroup: Criteria
A Phase 2 Study of B-701 in Treatment of Locally Advanced or Metastatic Urothelial Cell Carcinoma; ODM derived from: https://clinicaltrials.gov/show/NCT02401542

Swedish Bladder Cancer Registry - 5-Year Follow-Up

- 11/19/17 - 1 form, 2 itemgroups, 15 items, 2 languages
Itemgroups: General Information, Follow-Up
Swedish Bladder Cancer Registry Healthcare Quality http://www.cancercentrum.se/vast/cancerdiagnoser/urinvagar/urinblase--och-urinvagscancer/kvalitetsregister/dokument/ 5-year Follow-Up

Swedish Bladder Cancer Registry - Cystectomy - Follow-Up

- 11/18/17 - 1 form, 5 itemgroups, 106 items, 2 languages
Itemgroups: General Information, Preoperative Data, Perioperative Data, Postoperative Data, Complications and Reoperations
Swedish Bladder Cancer Registry Healthcare Quality http://www.cancercentrum.se/vast/cancerdiagnoser/urinvagar/urinblase--och-urinvagscancer/kvalitetsregister/dokument/ Cystectomy - Follow-Up

Swedish Bladder Cancer Registry - Treatment of Primary Tumor

- 11/15/17 - 1 form, 2 itemgroups, 30 items, 2 languages
Itemgroups: General Information, Treatment of Primary Tumor
Swedish Bladder Cancer Registry Healthcare Quality http://www.cancercentrum.se/vast/cancerdiagnoser/urinvagar/urinblase--och-urinvagscancer/kvalitetsregister/dokument/ Treatment of Primary Tumor

Swedish Bladder Cancer Registry - Registry

- 11/15/17 - 1 form, 2 itemgroups, 27 items, 2 languages
Itemgroups: Registry, Tasks for Primary Diagnosis
Swedish Bladder Cancer Registry Healthcare Quality http://www.cancercentrum.se/vast/cancerdiagnoser/urinvagar/urinblase--och-urinvagscancer/kvalitetsregister/dokument/ Registry

Eligibility Bladder Cancer NCT00389155

- 10/4/17 - 1 form, 2 itemgroups, 12 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
First-Line Treatment of Advanced Bladder Cancer Randomized vs. Gemcitabine ± Vinflunine in Patients Ineligible to Receive Cisplatin-Based Therapy; ODM derived from: https://clinicaltrials.gov/show/NCT00389155

Eligibility Carcinoma, Transitional Cell NCT00109655

- 11/7/16 - 1 form, 2 itemgroups, 11 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Dose-Escalation Study of CG0070 for Bladder Cancer After BCG (Bacillus Calmette-Guerin) Failure; ODM derived from: https://clinicaltrials.gov/show/NCT00109655

Eligibility Bladder Neoplasms NCT00001381

- 1/10/16 - 1 form, 1 itemgroup, 15 items, 1 language
Itemgroup: Criteria
A Phase I Trial Using Suramin to Treat Superficial Transitional Cell Carcinoma of the Bladder; ODM derived from: https://clinicaltrials.gov/show/NCT00001381

On-Study Form Bladder Cancer NCT00014534 CALGB-90104

- 8/21/15 - 1 form, 3 itemgroups, 61 items, 1 language
Itemgroups: Muscle Invasive Bladder Disease: Prior Treatment Affecting the Bladder, Prior Therapy Date, CCRR MODULE
On-Study Form Bladder Cancer NCT00014534 CALGB-90104 NCT00014534 NCI Cooperative Group On-Study Form-Revised (CALGB-90104) Combination Chemotherapy in Treating Patients With Bladder Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=BE1B6E9C-942E-7181-E034-0003BA12F5E7

Registration Bladder Cancer CALGB 90104 NCT00014534

- 7/30/15 - 1 form, 2 itemgroups, 34 items, 1 language
Itemgroups: Initial Patient Consent for Specimen Use, Registration
Registration Worksheet - 2169258v3.0 CALGB 90104 Registration Worksheet Combination Chemotherapy in Treating Patients With Bladder Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=BE1B0241-438C-6AC6-E034-0003BA12F5E7